Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950

Genome-scale CRISPR-Cas9 knockout screening in human cells

Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234

The metabolism of tumors in the body

Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416

Fundamentals of Cancer Metabolism

DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622

Understanding the Intersections between Metabolism and Cancer Biology

Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,369

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124

From Krebs to clinic: glutamine metabolism to cancer therapy

Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119

Metabolic determinants of tumour initiation

Brunner, J. S., & Finley, L. W. S. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00773-5 · Cited by 78

Riluzole: A neuroprotective drug with potential as a novel anti‑cancer agent (Review)

Blyufer, A., Lhamo, S., Tam, C., Tariq, I., Thavornwatanayong, T., & Mahajan, S. S. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5275 · Cited by 79

Sulfur Metabolism Under Stress

Miller, C. G., & Schmidt, E. E. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8151 · Cited by 78

KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition

Koppula, P., Olszewski, K. L., Zhang, Y., Kondiparthi, L., Liu, X., Lei, G., Das, M., Fang, B., Poyurovsky, M. V., & Gan, B. (2021) · iScience · doi:10.1016/j.isci.2021.102649 · Cited by 78

Discovery of Novel Aminobutanoic Acid-Based ASCT2 Inhibitors for the Treatment of Non-Small-Cell Lung Cancer

Qin, L., Cheng, X., Wang, S., Gong, G., Su, H., Huang, H., Chen, T., Damdinjav, D., Dorjsuren, B., Li, Z., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01093 · Cited by 72

Regulation of Ferroptosis by Amino Acid Metabolism in Cancer

Yang, J., Dai, X., Xu, H., Tang, Q., & Bi, F. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.64982 · Cited by 70

ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition

Zou, Z., Cheng, Q., Zhou, J., Guo, C., Hadjinicolaou, A. V., Salio, M., Liang, X., Yang, C., Du, Y., Yao, W., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113995 · Cited by 69

Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment

Hua, Y., Yang, S., Zhang, Y., Li, J., Wang, M., Yeerkenbieke, P., Liao, Q., & Liu, Q. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02925-5 · Cited by 74

Cell death pathologies: targeting death pathways and the immune system for cancer therapy

Pentimalli, F., Grelli, S., Daniele, N. D., Melino, G., & Amelio, I. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0052-x · Cited by 69

Determinants of nutrient limitation in cancer

Sullivan, M. R., & Heiden, M. G. V. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1611733 · Cited by 70

A second Warburg‐like effect in cancer metabolism: The metabolic shift of glutamine‐derived nitrogen

Kodama, M., & Nakayama, K. I. (2020) · BioEssays · doi:10.1002/bies.202000169 · Cited by 65

Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer

Beatty, A., Fink, L. S., Singh, T., Strigun, A., Peter, E., Ferrer, C. M., Nicolas, É., Cai, K. Q., Moran, T. P., Reginato, M. J., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0407 · Cited by 67

The CRL3 KCTD10 ubiquitin ligase–USP18 axis coordinately regulates cystine uptake and ferroptosis by modulating SLC7A11

Zhou, Q., Yu, H., Chen, Y., Ren, J., Lü, Y., & Sun, Y. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2320655121 · Cited by 67

Disulfidptosis: a novel cell death modality induced by actin cytoskeleton collapse and a promising target for cancer therapeutics

Li, T., Song, Y., Wei, L., Song, X., & Duan, R. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01871-9 · Cited by 66

Assessment of Tumor Redox Status through ( S )-4-(3-[18F]fluoropropyl)- L -Glutamic Acid PET Imaging of System xc− Activity

McCormick, P. N., Greenwood, H. E., Glaser, M., Maddocks, O. D. K., Gendron, T., Sander, K., Gowrishankar, G., Hoehne, A., Zhang, T., Shuhendler, A. J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2634 · Cited by 62

Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1

Tsai, P.-Y., Lee, M.-S., Jadhav, U., Naqvi, I., Madha, S., Adler, A., Mistry, M., Naumenko, S., Lewis, C. A., Hitchcock, D. S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003014118 · Cited by 67

The impact of physiological metabolite levels on serine uptake, synthesis and utilization in cancer cells

Hennequart, M., Labuschagne, C. F., Tajan, M., Pilley, S. E., Cheung, E. C., Legrave, N. M., Driscoll, P. C., & Vousden, K. H. (2021) · Nature Communications · doi:10.1038/s41467-021-26395-5 · Cited by 62

Polyamine pathway activity promotes cysteine essentiality in cancer cells

Zhang, T., Bauer, C., Newman, A. C., Uribe, A. H., Athineos, D., Blyth, K., & Maddocks, O. D. K. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0253-2 · Cited by 56

The bidirectional relationship between metabolism and cell cycle control

Diehl, F. F., Sapp, K. M., & Heiden, M. G. V. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.05.012 · Cited by 60

Mind your media

Lagziel, S., Gottlieb, E., & Shlomi, T. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00299-y · Cited by 58

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia

Stuani, L., Sabatier, M., & Sarry, J. (2019) · BMC Biology · doi:10.1186/s12915-019-0670-4 · Cited by 66

Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations

Hvinden, I. C., Cadoux-Hudson, T. A. D., Schofield, C. J., & McCullagh, J. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100469 · Cited by 63

Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells

Chowdhury, S., Kar, A., Bhowmik, D., Gautam, A., Basak, D., Sarkar, I., Ghosh, P., Sarkar, D., Deka, A., Chakraborty, P., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4052 · Cited by 58

Supply and demand: Cellular nutrient uptake and exchange in cancer

Papalazarou, V., & Maddocks, O. D. K. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.026 · Cited by 53

Exploiting metabolic vulnerabilities of Non small cell lung carcinoma

Majem, B., Nadal, E., & Muñoz‐Pinedo, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.06.004 · Cited by 57

Enzyme-mediated depletion of l-cyst(e)ine synergizes with thioredoxin reductase inhibition for suppression of pancreatic tumor growth

Kshattry, S., Saha, A., Gries, P., Tiziani, S., Stone, E. M., Georgiou, G., & DiGiovanni, J. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0088-z · Cited by 54

Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer

Singleton, D. C., Dechaume, A.-L., Murray, P. M., Katt, W. P., Baguley, B. C., & Leung, E. Y. (2020) · BMC Cancer · doi:10.1186/s12885-020-06885-3 · Cited by 56

Cysteine as a Carbon Source, a Hot Spot in Cancer Cells Survival

Serpa, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00947 · Cited by 55

Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression

DeBlasi, J. M., Falzone, A., Caldwell, S., Prieto-Farigua, N., Prigge, J. R., Schmidt, E. E., Chio, I. I. C., Karreth, F. A., & DeNicola, G. M. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3848 · Cited by 49

GAB functions as a bioenergetic and signalling gatekeeper to control T cell inflammation

Kang, S., Liu, L., Wang, T., Cannon, M. V., Lin, P., Fan, T. W. ‐., Scott, D. A., Wu, H.-J. J., Lane, A. N., & Wang, R. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00638-1 · Cited by 48

Immunometabolism in the Tumor Microenvironment

Roy, D. G., Kaymak, I., Williams, K. S., Ma, E. H., & Jones, R. G. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055817 · Cited by 49

A CRISPRi/a screening platform to study cellular nutrient transport in diverse microenvironments

Chidley, C., Darnell, A. M., Gaudio, B. L., Lien, E. C., Barbeau, A. M., Heiden, M. G. V., & Sorger, P. K. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01402-1 · Cited by 45

Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy

Sun, N.-Y., & Yang, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00792 · Cited by 48

Hydrogen sulfide coordinates glucose metabolism switch through destabilizing tetrameric pyruvate kinase M2

Wang, R., Chen, P., Chen, Y.-T., Chen, Y., Chu, Y.-H., Chien, C.-C., Chien, P.-C., Lo, S.-Y., Wang, Z., Tsou, M.-C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51875-9 · Cited by 46

Reverse engineering the cancer metabolic network using flux analysis to understand drivers of human disease

Badur, M. G., & Metallo, C. M. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.11.013 · Cited by 44

Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring

Scalise, M., Console, L., Rovella, F., Galluccio, M., Pochini, L., & Indiveri, C. (2020) · Cells · doi:10.3390/cells9092028 · Cited by 45

Flexibility and Adaptation of Cancer Cells in a Heterogenous Metabolic Microenvironment

Bluemel, G., Mondal, A., & Leithner, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031476 · Cited by 44

Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes

Galicia-Vázquez, G., & Aloyz, R. S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00411 · Cited by 45

Therapeutic Targeting of the GLS1–c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer

Yang, J., Chen, F., Lang, L., Yang, F., Fu, Z., Martínez, J., Cho, A., Saba, N. F., & Teng, Y. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0254 · Cited by 45

Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation

de la Oliva, A. R. L., Campos-Sandoval, J. A., Gómez-García, M. C., Cardona, C., Martín‐Rufián, M., Sialana, F. J., Castilla, L., Bae, N., Lobo, C., Peñalver, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58264-4 · Cited by 42

Metabolites and Immune Response in Tumor Microenvironments

Cortellino, S., & Longo, V. D. (2023) · Cancers · doi:10.3390/cancers15153898 · Cited by 43

The amino acid transporter SLC7A11 expression in breast cancer

Nath, P., Alfarsi, L. H., Ansari, R. E., Masisi, B. K., Erkan, B., Fakroun, A., Ellis, I. O., Rakha, E. A., & Green, A. R. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2291855 · Cited by 42

Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283

Pelaz, S. G., Jaraíz-Rodríguez, M., Álvarez-Vázquez, A., Talaverón, R., García-Vicente, L., Flores-Hernández, R., de Cedrón, M. G., Tabernero, M., de Molina, A. R., Lillo, C., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103134 · Cited by 40

Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumors

Choi, B.-H., Rawat, V., Högström, J., Burns, P. A., Conger, K. O., Özgürses, M. E., Patel, J. M., Mehta, T. S., Warren, A., Selfors, L. M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110278 · Cited by 38

Inhibition of ALG3 stimulates cancer cell immunogenic ferroptosis to potentiate immunotherapy

Liu, P., Lin, C., Liu, Z., Zhu, C., Lin, Z., Xu, D., Chen, J., Huang, Q., Li, C., Hou, L., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04365-4 · Cited by 38

Flavonoids and cellular stress: a complex interplay affecting human health

Vissenaekens, H., Criel, H., Grootaert, C., Raes, K., Smagghe, G. J., & Camp, J. V. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1929822 · Cited by 40

A Single‐Cell Metabolic Profiling Characterizes Human Aging via SlipChip‐SERS

Liu, F., Liu, J., Luo, Y., Wu, S., Liu, X., Chen, H., Luo, Z., Yuan, H., Shen, F., Zhu, F., et al. (2024) · Advanced Science · doi:10.1002/advs.202406668 · Cited by 37

Ferroptosis in cancer: metabolism, mechanisms and therapeutic prospects

Wu, Y., Li, H., Yue, K., Jing, C., & Duan, Y. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02520-6 · Cited by 44

Glutamine uptake and utilization of human mesenchymal glioblastoma in orthotopic mouse model

Oizel, K., Yang, C., Renoult, O., Gautier, F., Do, Q. N., Joalland, N., Gao, X., Ko, B., Vallette, F. M., Ge, W., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00215-8 · Cited by 37

Progress in research on the role of amino acid metabolic reprogramming in tumour therapy: A review

Wang, D., & Wan, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113923 · Cited by 34

Rapid nutrient depletion to below the physiological range by cancer cells cultured in Plasmax

Gardner, G. L., Moradi, F., Moffatt, C., Cliche, M., Garlisi, B., Gratton, J., Mehmood, F., & Stuart, J. A. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00403.2021 · Cited by 36

Epigenetic–Metabolic Interplay in the DNA Damage Response and Therapeutic Resistance of Breast Cancer

Das, C., Adhikari, S., Bhattacharya, A., Chakraborty, S., Mondal, P., Yadav, S. S., Adhikary, S., Hunt, C. R., Yadav, K. K., Pandita, S., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3015 · Cited by 39

Targeting ALDH1A1 to enhance the efficacy of KRAS-targeted therapy through ferroptosis

Bian, Y., Shan, G., Bi, G., Liang, J., Hu, Z., Sui, Q., Shi, H., Zheng, Z., Yao, G., Wang, Q., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103361 · Cited by 34

Nutrient availability shapes methionine metabolism in p16/ MTAP -deleted cells

Sanderson, S. M., Mikhael, P. G., Ramesh, V., Dai, Z., & Locasale, J. W. (2019) · Science Advances · doi:10.1126/sciadv.aav7769 · Cited by 36

Screening in serum-derived medium reveals differential response to compounds targeting metabolism

Abbott, K. L., Ali, A., Casalena, D. E., Do, B. T., Ferreira, R., Cheah, J. H., Soule, C. K., Deik, A., Kunchok, T., Schmidt, D. R., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.08.007 · Cited by 35

The unique catalytic properties of PSAT1 mediate metabolic adaptation to glutamine blockade

Qiu, Y., Stamatatos, O. T., Hu, Q., Swain, J. D. R., Russo, S., Sann, A., Costa, A. S. H., Violante, S. N., Spector, D. L., Cross, J. R., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01104-w · Cited by 34

Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity

Rivera, G. O. R., Dwyer, C. J., Knochelmann, H. M., Smith, A. S., Aksoy, B. A., Cole, A. C., Wyatt, M. M., Kumaresan, S., Thaxton, J. E., Lesinski, G. B., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0801 · Cited by 30

In vivo assessment of glutamine anaplerosis into the TCA cycle in human pre-malignant and malignant clonal plasma cells

Gonsalves, W. I., Jang, J. S., Jessen, E., Hitosugi, T., Evans, L. A., Jevremović, D., Pettersson, X.-M., Bush, A. G., Gransee, J., Anderson, E. I., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00235-4 · Cited by 34

The influence of medium formulation on phosphomonoester and UDP‐Hexose levels in cultured human colon tumor cells as observed by 31P NMR spectroscopy

Shedd, S. F., Lutz, N. W., & Hull, W. E. (1993) · NMR in Biomedicine · doi:10.1002/nbm.1940060405 · Cited by 31

Challenges in Studying Stem Cell Metabolism

Perez-Ramirez, C. A., & Christofk, H. R. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.02.016 · Cited by 30

The Effect of Oxygen and Micronutrient Composition of Cell Growth Media on Cancer Cell Bioenergetics and Mitochondrial Networks

Moradi, F., Moffatt, C., & Stuart, J. A. (2021) · Biomolecules · doi:10.3390/biom11081177 · Cited by 30

Glucose restriction induces AMPK-SIRT1-mediated circadian clock gene Per expression and delays NSCLC progression

Li, B., Chen, Q., Feng, Y., Wei, T., Zhang, Y., Zhang, Y., & Feng, Q. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216424 · Cited by 31

Glutathione dynamics in subcellular compartments and implications for drug development

Lin, H., Wang, L., Jiang, X., & Wang, J. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102505 · Cited by 32

Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know?

Galicia-Vázquez, G., & Aloyz, R. S. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.12.003 · Cited by 30

Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer

Zhao, X., Fu, J., Hu, B., Chen, L., Wang, J., Fang, J., Ge, C., Lin, H., Pan, K., Fu, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639111 · Cited by 28

A PDX1-ATF transcriptional complex governs β cell survival during stress

Juliana, C. A., Yang, J., Cannon, C. E., Good, A. L., Haemmerle, M. W., & Stoffers, D. A. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.07.007 · Cited by 31

Metabolic Regulation of the Epitranscriptome

Thomas, J. M., Batista, P. J., & Meier, J. L. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b00951 · Cited by 30

Cysteine is a limiting factor for glioma proliferation and survival

Ruiz‐Rodado, V., Dowdy, T., Lita, A., Kramp, T. R., Zhang, M., Jung, J., Dios‐Esponera, A., Zhang, L., Herold‐Mende, C. C., Camphausen, K. A., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13148 · Cited by 30

Exploring Amino Acid Transporters as Therapeutic Targets for Cancer: An Examination of Inhibitor Structures, Selectivity Issues, and Discovery Approaches

Jakobsen, S., & Nielsen, C. U. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020197 · Cited by 28

Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy

Nair, R., Gupta, P., & Shanmugam, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1000106 · Cited by 29

Ferroptosis, Metabolic Rewiring, and Endometrial Cancer

Žalytė, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010075 · Cited by 29

Multistability maintains redox homeostasis in human cells

Huang, J., Co, H. K. C., Lee, Y., Wu, C., & Chen, S. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110480 · Cited by 26

Multiple Faces of the Glioblastoma Microenvironment

Șovrea, A. S., Boșca, B., Melincovici, C. S., Constantin, A.-M., Crintea, A., Mărginean, M., Dronca, E., Jianu, M. E., Suflețel, R., Gonciar, D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020595 · Cited by 26

Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy DevelopmentPreprint

Estape, A. A., Foggetti, G., Starrett, J. H., Nguyen, D. X., & Politi, K. A. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037820 · Cited by 23

Metabolomics and cellular altered pathways in cancer biology: A review

Bhardwaj, J. K., Siwach, A., & Sachdeva, S. N. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23807 · Cited by 27

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy

Cuyàs, E., Verdura, S., Martín-Castillo, B., Alarcón, T., Lupu, R., Bosch‐Barrera, J., & Menéndez, J. A. (2020) · Cancers · doi:10.3390/cancers12071757 · Cited by 26

Metabolomics analysis identifies glutamic acid and cystine imbalances in COVID-19 patients without comorbid conditions. Implications on redox homeostasis and COVID-19 pathophysiology

Páez-Franco, J. C., Maravillas‐Montero, J. L., Mejía‐Domínguez, N. R., Torres-Ruiz, J. J., Tamez-Torres, K. M., Pérez‐Fragoso, A., Germán-Acacio, J. M., Ponce‐de‐León, A., Gómez‐Martín, D., & Ulloa‐Aguirre, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274910 · Cited by 24

Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease

Chauhan, W., & Zennadi, R. (2023) · Antioxidants · doi:10.3390/antiox12030740 · Cited by 27

Maf1 phenotypes and cell physiology

Willis, I. M. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.11.009 · Cited by 25

Nutrient requirements of organ-specific metastasis in breast cancer

Abbott, K. L., Subudhi, S., Ferreira, R., Gültekin, Y., Steinbuch, S. C., Munim, M. B., Ramesh, D. L., Honeder, S. E., Kumar, A. S., Wu, M., et al. (2026) · Nature · doi:10.1038/s41586-025-09898-9 · Cited by 35

Beyond glucose and Warburg: finding the sweet spot in cancer metabolism models

Hammond, N. G., Cameron, R. B., & Faubert, B. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00017-2 · Cited by 23

Metabolic adaptations in cancer progression

Peng‐Winkler, Y., & Fendt, S. (2025) · Physiological Reviews · doi:10.1152/physrev.00037.2024 · Cited by 25

Tumor metabolism rewiring in epithelial ovarian cancer

Wang, M., Zhang, J., & Wu, Y. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01196-0 · Cited by 27

Celastrol-loaded ginsenoside Rg3 liposomes boost immunotherapy by remodeling obesity-related immunosuppressive tumor microenvironment in melanoma

Zhang, H., Huang, J., Li, Y., Jin, W., Wei, J., Ma, N., Shen, L., Gu, M., Mu, C., Xu, D., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.017 · Cited by 24

Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma

Khadka, S., Arthur, K., Barekatain, Y., Behr, E., Washington, M., Ackroyd, J. J., Crowley, K., Suriyamongkol, P., Lin, Y.-H., Pham, C.-D., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00259-4 · Cited by 21

Rethinking the Roles of Cancer-Associated Fibroblasts in Pancreatic Cancer

Francescone, R., Crawford, H. C., & Costa, D. B. V. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.022 · Cited by 20

Metabolic Reprogramming is a Hallmark of Metabolism Itself

Medina, M. Á. (2020) · BioEssays · doi:10.1002/bies.202000058 · Cited by 24

Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance

Bailleul, J., & Vlashi, E. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0088 · Cited by 22

Acquired deficiency of peroxisomal dicarboxylic acid catabolism is a metabolic vulnerability in hepatoblastoma

Wang, H., Lu, J. L., Chen, X., Schwalbe, M., Gorka, J. E., Mandel, J. A., Wang, J., Goetzman, E. S., Ranganathan, S., Dobrowolski, S. F., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100283 · Cited by 21

Therapeutic Targeting of Glutaminolysis as a Novel Strategy to Combat Cancer Stem Cells

Kao, T., Chuang, Y.-C., Lee, H., Kuo, C., & Shen, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315296 · Cited by 19

Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability

Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2024) · eLife · doi:10.7554/elife.95652 · Cited by 22

Targeting Therapy Resistance: When Glutamine Catabolism Becomes Essential

Lukey, M. J., Katt, W. P., & Cerione, R. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.009 · Cited by 19

Two Faces of Glutaminase GLS2 in Carcinogenesis

Buczkowska, J., & Szeliga, M. (2023) · Cancers · doi:10.3390/cancers15235566 · Cited by 21

Targeting Metabolic Bottlenecks in Lung Cancer

Sayin, V. I., LeBoeuf, S. E., & Papagiannakopoulos, T. Y. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.06.001 · Cited by 18

Exploring the evolutionary roots and physiological function of itaconate

Cordes, T., & Metallo, C. M. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.11.005 · Cited by 18

Netrin G1 promotes pancreatic tumorigenesis through cancer associated fibroblast driven nutritional support and immunosuppressionPreprint

Francescone, R., Costa, D. B. V., Franco-Barraza, J., Wagner, J., Muir, A., Lau, A. N., Gabitova, L., Pazina, T., Gupta, S., Luong, T., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/330209 · Cited by 18

Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions

Flickinger, K. M., Wilson, K. M., Rossiter, N. J., Hunger, A. L., Vishwasrao, P., Lee, T. D., Fritz, C. M., Richards, R. M., Hall, M. D., & Cantor, J. R. (2024) · Science Advances · doi:10.1126/sciadv.adq3591 · Cited by 18

Long noncoding RNA CASC11 suppresses sorafenib-triggered ferroptosis via stabilizing SLC7A11 mRNA in hepatocellular carcinoma cells

Chen, F., & Wang, L. (2023) · Discover Oncology · doi:10.1007/s12672-023-00761-9 · Cited by 16

A histone deacetylase 3 and mitochondrial complex I axis regulates toxic formaldehyde production

Wit, N., Gogola, E., West, J. A., Vornbäumen, T., Seear, R., Bailey, P. S. J., Burgos-Barragan, G., Wang, M., Krawczyk, P. A., Huberts, D. H. E. W., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg2235 · Cited by 18

Kruppel-like factor 2 disturb non-small cell lung cancer energy metabolism by inhibited glutamine consumption

Song, X., Jin-xiang, Y., Long, T., Lu, X., Hong, G., Jie‐Cheng, Y., & Fei, Z. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13252 · Cited by 15

Untitled work

Collins (1998) · doi:10.1002/(sici)1097-4652(199807)176:1

Pyruvate carboxylase is required for glutamine-independent growth of tumor cells

Cheng, T., Sudderth, J., Yang, C., Mullen, A. R., Jin, E. S., Matés, J. M., & DeBerardinis, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016627108 · Cited by 475

CRL3 E3 ligase regulates glutamine and cystine metabolisms

Zhou, Q., Li, Z., & Sun, Y. (2024) · Protein & Cell · doi:10.1093/procel/pwae051 · Cited by 2

Abstract B39: Asparagine drives translational adaptation of cancer cells to glutamine deficit

Pavlova, N. N., Zhang, J., & Thompson, C. B. (2017) · Cancer Research · doi:10.1158/1538-7445.transcontrol16-b39

STARVING CANCER: A STUDY OF GLUTAMINE DEPENDENCY IN CANCER CELLS

Bingham, G. E. (2014)